Infinity Pharmaceuticals Story Overview

INFI -- USA Stock  

USD 1.91  0.07  3.54%

Macroaxis does not monitor all media channels or aggregates social signals for Infinity Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Infinity Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Infinity Pharmaceuticals. Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance.
Infinity Pharmaceuticals, Inc. Stock Price trades -36.54 percent off from 200- SMA
Infinity Pharmaceuticals, Inc. stock price is at a -69.53 percent downfall to its 52-week high and above .25 percent to a 52-week low. Contrasting Mesoblast limited and Infinity Pharmaceuticals - TrueBlueTribune

Read More...   

Story Momentum

This media report from www.analystsbuzz.com distributed on September 28, 2017 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 16.67% . The trading delta at closing time when the story was published against the current closing price is 71.93% .

Similar stores for Infinity Pharmaceuticals

3 days ago at http://nysewired.com 
Notable Stock to Watch Infinity Pharmaceuticals, Inc.
wired  News
NYSE WIRED Full coverage
over a week ago at http://hillaryhq.com 
Regions Financial Stake in Oracle Has Trimmed by 13.54 Million as Stock Value Declined Skyline Asset ...
news
Hillary HQ Full coverage
over a week ago at http://mtlnewsjournal.com 
What Can Infinity Pharmaceuticals, Inc. s Quant Signals Tell Us About the Shares
wsj  News
MTL NewsInfinity Pharmaceuticals Inc Institutional Investor Sentiment Analysis MoneyMakingArticlesInstitutional Investors Are Betting On Infinity Pharmaceuticals Inc Thorold NewsFull coverage
over two weeks ago at http://www.thewellesleysnews.com 
Stock-research Ratings Infinity Pharmaceuticals, Inc. , EnLink Midstream Partners, LP
news
Analyst JournalThis High-Yield Growth Stock Is in a League of Its Own Motley FoolFull coverage
over three weeks ago at http://www.thestreetpoint.com 
These Will Blow Your Mind Xenetic Biosciences, Inc. , Spirit Realty Capital, Inc. , Infinity ...
Thestreet News
The Stock Street Full coverage
over three weeks ago at http://www.thestocksnews.com 
Monthly loser Infinity Pharmaceuticals, Inc. stock performed -15.27 percent down
news
The Stocks News Full coverage
over a month ago at http://nasdaqplace.com 
News Report of Sizzling Healthcare Stock Infinity Pharmaceuticals, Inc.
nasdaq News
Nasdaq Place Full coverage
over a month ago at http://stockspen.com 
Acquisition by Jeffrey Berkowitz of 20000 shares of Infinity Pharmaceuticals subject to Rule 16b-3
news
Filed transaction by Infinity Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at http://www.zacks.com 
Infinity Pharmaceuticals Down 6.7 percent Since Earnings Report Can It Rebound
zacks News
Zacks.comRelative Strength Index Analysis Report Infinity Pharmaceuticals, Inc. , Knoll, Inc. CBRE Group, Inc. Is At 48.06 Formed Wedge Infinity Pharmaceuticals Has 1.32 Sentiment Technology Newsroom Full coverage
over a month ago at http://thewellesleysnews.com 
Analyst Research and Ratings Infinity Pharmaceuticals, Inc. , Internap Corporation
news
Analyst JournalFull coverage
over two months ago at http://thewellesleysnews.com 
Stock-research Ratings Infinity Pharmaceuticals, Inc. , Windstream Holdings, Inc.
news
Analyst JournalFull coverage
over three months ago at http://alphabetastock.com 
Comprehensive Stock Analysis Infinity Pharmaceuticals Inc
news
Alpha Beta StockThese stocks might change the kismet of Investors Seagate Technology plc, , Infinity Pharmaceuticals ... Global Export Lines Are These Stocks A Sure Bet Morgan Stanley , Infinity Pharmaceuticals, Inc. StockNewsGazetteFull coverage
over three months ago at http://www.prnewswire.com 
Infinity To Present At BIO CEO and Investor Conference
prnewswire News
CAMBRIDGE, Mass., Feb. 5, 2018 PRNewswire -- Infinity Pharmaceuticals, Inc. announced today that Adelene Perkins, Infinity Pharmaceutical chief executive officer, will present at the BIO CEO and Investor Conference on Monday, February ...

Price to Earnings To Growth

Price to Earnings To Growth Comparative Analysis
  Price to Earnings To Growth 
      Infinity Pharmaceuticals Comparables 
Infinity Pharmaceuticals is currently under evaluation in price to earnings to growth category among related companies. PEG Ratio indicates potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate.Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates future growth of a firm. The low PEG ratio usually implies that equity instrument is undervalued; where as PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

Peers

Infinity Pharmaceuticals Related Equities
GSK  2.80 %   
0%
100.0%
GRFS  2.63 %   
0%
93.0%
NVS  1.87 %   
0%
66.0%
NVO  1.26 %   
0%
45.0%
SNY  1.17 %   
0%
41.0%
AZN  0.49 %   
0%
17.0%
ALNY  0.29 %   
0%
10.0%
NBIX  0.19 %   
0%
6.0%
TEVA  0.3 %   
10.0%
0%
SHPG  0.84 %   
29.0%
0%
Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">